Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy

BACKGROUND: Hypoxic-ischemic encephalopathy (HIE) is a leading cause of morbidity and mortality in the adult as well as in the neonate, with limited options for treatment and significant dysfunctionality. AIM: To investigate the safety and preliminary efficacy of allogeneic mesenchymal stem cells (M...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabataş, Serdar, Civelek, Erdinç, Kaplan, Necati, Savrunlu, Eyüp Can, Sezen, Gülseli Berivan, Chasan, Mourat, Can, Halil, Genç, Ali, Akyuva, Yener, Boyalı, Osman, Diren, Furkan, Karaoz, Erdal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010270/
https://www.ncbi.nlm.nih.gov/pubmed/33821203
http://dx.doi.org/10.5493/wjem.v11.i2.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010270/
https://www.ncbi.nlm.nih.gov/pubmed/33821203
http://dx.doi.org/10.5493/wjem.v11.i2.17

Ejemplares similares